1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Clopidogrel (Plavix) 1.2.3 Prasugrel (Effient) 1.2.4 Ticagrelor (Brilinta) 1.2.5 Vorapaxar (Zontivity) 1.2.6 Others 1.3 Market by Application 1.3.1 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Perspective (2016-2027) 2.2 Peripheral Arterial Disease (PAD) Drugs Growth Trends by Regions 2.2.1 Peripheral Arterial Disease (PAD) Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Peripheral Arterial Disease (PAD) Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Peripheral Arterial Disease (PAD) Drugs Industry Dynamic 2.3.1 Peripheral Arterial Disease (PAD) Drugs Market Trends 2.3.2 Peripheral Arterial Disease (PAD) Drugs Market Drivers 2.3.3 Peripheral Arterial Disease (PAD) Drugs Market Challenges 2.3.4 Peripheral Arterial Disease (PAD) Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue 3.1.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue (2016-2021) 3.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Drugs Revenue 3.4 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio 3.4.1 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Drugs Revenue in 2020 3.5 Peripheral Arterial Disease (PAD) Drugs Key Players Head office and Area Served 3.6 Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service 3.7 Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Type 4.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Type (2016-2021) 4.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2022-2027) 5 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Application 5.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Application (2016-2021) 5.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027) 6.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type 6.2.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) 6.2.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) 6.2.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027) 6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application 6.3.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) 6.3.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) 6.3.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027) 6.4 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country 6.4.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) 6.4.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027) 7.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type 7.2.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) 7.2.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) 7.2.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027) 7.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application 7.3.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) 7.3.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) 7.3.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027) 7.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country 7.4.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) 7.4.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027) 8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type 8.2.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application 8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region 8.4.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027) 9.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type 9.2.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027) 9.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application 9.3.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027) 9.4 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country 9.4.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size (2016-2027) 10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type 10.2.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application 10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country 10.4.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 AstraZeneca (UK) 11.1.1 AstraZeneca (UK) Company Details 11.1.2 AstraZeneca (UK) Business Overview 11.1.3 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Introduction 11.1.4 AstraZeneca (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.1.5 AstraZeneca (UK) Recent Development 11.2 Bayer HealthCare Pharmaceuticals (Germany) 11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details 11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview 11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Introduction 11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Development 11.3 Bristol-Myers Squibb Company (US) 11.3.1 Bristol-Myers Squibb Company (US) Company Details 11.3.2 Bristol-Myers Squibb Company (US) Business Overview 11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Introduction 11.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.3.5 Bristol-Myers Squibb Company (US) Recent Development 11.4 Merck & Co (US) 11.4.1 Merck & Co (US) Company Details 11.4.2 Merck & Co (US) Business Overview 11.4.3 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Introduction 11.4.4 Merck & Co (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.4.5 Merck & Co (US) Recent Development 11.5 Proteon Therapeutics (US) 11.5.1 Proteon Therapeutics (US) Company Details 11.5.2 Proteon Therapeutics (US) Business Overview 11.5.3 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Introduction 11.5.4 Proteon Therapeutics (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.5.5 Proteon Therapeutics (US) Recent Development 11.6 Sanofi (France) 11.6.1 Sanofi (France) Company Details 11.6.2 Sanofi (France) Business Overview 11.6.3 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Introduction 11.6.4 Sanofi (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.6.5 Sanofi (France) Recent Development 11.7 Symic Bio (US) 11.7.1 Symic Bio (US) Company Details 11.7.2 Symic Bio (US) Business Overview 11.7.3 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Introduction 11.7.4 Symic Bio (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.7.5 Symic Bio (US) Recent Development 11.8 TheraVasc (US) 11.8.1 TheraVasc (US) Company Details 11.8.2 TheraVasc (US) Business Overview 11.8.3 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Introduction 11.8.4 TheraVasc (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) 11.8.5 TheraVasc (US) Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Clopidogrel (Plavix) Table 3. Key Players of Prasugrel (Effient) Table 4. Key Players of Ticagrelor (Brilinta) Table 5. Key Players of Vorapaxar (Zontivity) Table 6. Key Players of Others Table 7. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2016-2021) Table 11. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2022-2027) Table 13. Peripheral Arterial Disease (PAD) Drugs Market Trends Table 14. Peripheral Arterial Disease (PAD) Drugs Market Drivers Table 15. Peripheral Arterial Disease (PAD) Drugs Market Challenges Table 16. Peripheral Arterial Disease (PAD) Drugs Market Restraints Table 17. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players (2016-2021) Table 19. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2020) Table 20. Ranking of Global Top Peripheral Arterial Disease (PAD) Drugs Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service Table 24. Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million) Table 27. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2016-2021) Table 28. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Peripheral Arterial Disease (PAD) Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2016-2021) Table 32. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million) Table 35. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million) Table 37. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2022-2027) & (US$ Million) Table 64. AstraZeneca (UK) Company Details Table 65. AstraZeneca (UK) Business Overview Table 66. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Product Table 67. AstraZeneca (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 68. AstraZeneca (UK) Recent Development Table 69. Bayer HealthCare Pharmaceuticals (Germany) Company Details Table 70. Bayer HealthCare Pharmaceuticals (Germany) Business Overview Table 71. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product Table 72. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 73. Bayer HealthCare Pharmaceuticals (Germany) Recent Development Table 74. Bristol-Myers Squibb Company (US) Company Details Table 75. Bristol-Myers Squibb Company (US) Business Overview Table 76. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product Table 77. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 78. Bristol-Myers Squibb Company (US) Recent Development Table 79. Merck & Co (US) Company Details Table 80. Merck & Co (US) Business Overview Table 81. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Product Table 82. Merck & Co (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 83. Merck & Co (US) Recent Development Table 84. Proteon Therapeutics (US) Company Details Table 85. Proteon Therapeutics (US) Business Overview Table 86. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Product Table 87. Proteon Therapeutics (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 88. Proteon Therapeutics (US) Recent Development Table 89. Sanofi (France) Company Details Table 90. Sanofi (France) Business Overview Table 91. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Product Table 92. Sanofi (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 93. Sanofi (France) Recent Development Table 94. Symic Bio (US) Company Details Table 95. Symic Bio (US) Business Overview Table 96. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Product Table 97. Symic Bio (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 98. Symic Bio (US) Recent Development Table 99. TheraVasc (US) Company Details Table 100. TheraVasc (US) Business Overview Table 101. TheraVasc (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) & (US$ Million) Table 102. TheraVasc (US) Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type: 2020 VS 2027 Figure 2. Clopidogrel (Plavix) Features Figure 3. Prasugrel (Effient) Features Figure 4. Ticagrelor (Brilinta) Features Figure 5. Vorapaxar (Zontivity) Features Figure 6. Others Features Figure 7. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2020 VS 2027 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Peripheral Arterial Disease (PAD) Drugs Report Years Considered Figure 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions: 2020 VS 2027 Figure 15. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Regions (2022-2027) Figure 16. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players in 2020 Figure 17. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2020 Figure 19. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2016-2021) Figure 20. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2022-2027) Figure 21. North America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027) Figure 23. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027) Figure 24. North America Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027) Figure 25. United States Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027) Figure 29. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027) Figure 30. Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027) Figure 31. Germany Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027) Figure 39. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027) Figure 40. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Region (2016-2027) Figure 41. China Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027) Figure 49. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027) Figure 50. Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027) Figure 51. Mexico Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2016-2027) Figure 55. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2016-2027) Figure 56. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Country (2016-2027) Figure 57. Turkey Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. AstraZeneca (UK) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 61. Bayer HealthCare Pharmaceuticals (Germany) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 62. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 63. Merck & Co (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 64. Proteon Therapeutics (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 65. Sanofi (France) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 66. Symic Bio (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 67. TheraVasc (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

AstraZeneca (UK) Bayer HealthCare Pharmaceuticals (Germany) Bristol-Myers Squibb Company (US) Merck & Co (US) Proteon Therapeutics (US) Sanofi (France) Symic Bio (US) TheraVasc (US)